You have missed nothing in that regard.
This is the only new thing said about licenses:
THC Pharma will expedite its applications to the Office of Drug Control for necessary approvals to both commence processing in its biomanufacturing facility and, pursuant to the Term Sheet entered into by THC with Meluka Health (ASX: 3 May 2018), will apply for relevant applications and licences to enable the growing of organic medicinal cannabis on the northern NSW property.
- Forums
- ASX - By Stock
- EPN
- ODC Meeting
ODC Meeting, page-2
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPN (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable